IFNA1 and systemic lupus erythematosus: An orthogonal approach was taken by calculating Z scores using both increased and decreased transcripts from PBMC-derived IFN39 or the MS-IFNB141 signatures to determine the most likely IFN active in SLE patient WB, PBMC, and affected tissues.